Episode 201: AMD Drug Updates with Dr. Allen Ho, including Gene Therapy

Related

• 

  GATHER2 Phase 3 Efficacy Results and GATHER2 Phase 3 Safety Results

  Jeffrey S. Heier, MD

  Arshad M. Khanani, MD, MA, FASRS

  Updates from the Field

  2022

• 

  ADVM-022 Intravitreal Gene Therapy for Neovascular AMD: Phase 1 OPTIC Trial Update

  Dante Joseph Pieramici, MD

  Annual Meeting Talks

  2022

• 

  Intravitreal Gene Therapy for Neovascular AMD with ADVM-022: Results of the Phase 1 OPTIC Trial

  Dante Joseph Pieramici, MD

  Annual Meeting Talks

  2021